Results 161 to 170 of about 59,823 (200)

Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011-2021). [PDF]

Curr Oncol
Aleksi A, Jobin KD, Hannouf MB, Husi P, Halperin H, White-Gloria C, Abedin T, Ruether D.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Temozolomide

Reactions Weekly, 2021
  +7 more sources

Temozolomide

Reactions Weekly, 2022
  +5 more sources

Temozolomide

Reactions Weekly, 2023
  +4 more sources

Temozolomide

Reactions Weekly, 2020
  +4 more sources

Temozolomide

Reactions Weekly, 2011
  +4 more sources

Temozolomide

Reactions Weekly, 2019
  +5 more sources

Temozolomide

Reactions Weekly
Frank Gaillard, Rohit Sharma, Michael Dieckmeyer   +2 more
  +6 more sources